Recent ADTX News
- Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024 • Business Wire • 09/27/2024 12:15:00 PM
- Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt • Business Wire • 09/24/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 09:23:03 PM
- Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025 • Business Wire • 09/20/2024 12:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/16/2024 08:20:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/16/2024 04:15:14 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/11/2024 09:20:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:15:39 PM
- Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024 • Business Wire • 09/09/2024 12:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/06/2024 09:04:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/06/2024 08:16:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:22:30 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:18:07 PM
- Aditxt Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients • Business Wire • 09/04/2024 12:15:00 PM
- Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024 • Business Wire • 08/29/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:30:21 PM
- Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) • Business Wire • 08/26/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:44:14 PM
- Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics • Business Wire • 08/21/2024 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:16:12 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:15:25 PM
- Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 • PR Newswire (US) • 08/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:15:09 PM
- Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic Plans • Business Wire • 08/13/2024 12:15:00 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM